Methylene Blue for Vasoplegic Syndrome after Cardiac Surgery: Early Administration Improves Survival

BACKGROUND: Vasoplegic syndrome, defined by hypotension despite normal or increased cardiac output, is associated with high mortality after cardiopulmonary bypass. Methylene blue (MB) is reported to ameliorate vasoplegic syndrome through the nitric oxide pathway. We hypothesized that early administr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Thorac Surg
Glavni autori: Mehaffey, J. Hunter, Johnston, Lily E., Hawkins, Robert B., Charles, Eric J., Yarboro, Leora, Kern, John A., Ailawadi, Gorav, Kron, Irving L., Ghanta, Ravi K.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523819/
https://ncbi.nlm.nih.gov/pubmed/28551045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.02.057
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items